| Feike Sijbesma | |
| Birth Place: | Nieuw-Loosdrecht, Netherlands |
| Alma Mater: | Utrecht University (MSc) Erasmus University Rotterdam (MBA) |
| Occupation: | Business executive |
| Known For: | CEO of Royal DSM (2007–2020)< |
Feike Sijbesma (born 1959) is a Dutch business executive who was CEO and chairman of the managing board of DSM from 2007 until 2020. And in 2022, he was nominated as honorary chairman. He helped the Dutch government from March to September 2020 as special voluntary corona envoy, especially focused on testing policy and availability. From mid 2020, Sijbesma focuses on several board positions (among others chairman of Philips and Unilever) and the African malnutrition issue and climate (adaptation).
Sijbesma was born in Nieuw-Loosdrecht, Netherlands in 1959. His father was an insurance agent. Sijbesma graduated with a Master of Science in molecular and medical biology from Utrecht University and a Master of Business Administration from Erasmus University Rotterdam.[1] [2]
After graduating from Erasmus University Rotterdam in 1987, Sijbesma started his career in the pharmaceuticals division of the Dutch biotechnology company, Gist-brocades NV.[1] First in strategy, then business development and accordingly as Director Marketing & Sales. In 1993, he was appointed general manager of the Savoury Business Unit at Gist-brocades.[3] Two years later, he was appointed to the company's executive committee.[4] In 1995 he became director of the Food Specialties Division of Gist-brocades. In 1998, Gist-brocades was acquired by Royal DSM.[1] [5] After the merger, Sijbesma became the director of DSM Food Specialties.[2] [6]
In 2000, Sijbesma joined the Managing Board of Directors (Executive Committee) at DSM as the company shifted toward nutrition and biotech.[1] [4] [7] In 2002/2003 Sijbesma led from Basel (Switzerland) the acquisition of Roche Vitamins & Fine Chemicals, which changed DSM drastically. In May 2007, he was named CEO of the company and Chairman of the Managing Board.[8] [9] As DSM CEO, Sijbesma transformed the company into a life science and material science company.[9] The company sold its petrochemical and bulk-chemical businesses, as well as its pharmaceutical units.[1] During that time, Sijbesma also oversaw 25 major acquisitions for the company.[10] Additionally, Sijbesma brought DSM into a partnership with the United Nations' World Food Programme (WFP) to provide food assistance to tens of millions of people via WFP. Sijbesma also founded Africa Improved Foods addressing hunger in Africa via local manufacturing, starting in Rwanda[11] In 2010, Sijbesma was given the United Nations Humanitarian of the Year award.[12]
In 2016, Sijbesma was named Co-Chair of the High Level Assembly of the Carbon Pricing Leadership Coalition (CPLC) which was convened by the World Bank Group.[13] In 2017, the World Bank Group named him a "Global Climate Leader."[14] He also advocated for widespread corporate and governmental use of carbon pricing in 2017.[15]
Early 2020, after 13 years at the helm, Sijbesma handed over the CEO ship of DSM to his successors, Dimitri de Vreeze and Geraldine Matchett as co-CEO's, whilst Sijbesma was named as honorary chair of DSM. Under Sijbesma's leadership DSM transformed from a bulk-chemical company into one focused at nutrition, health and sustainable living.[16]
In 2020, the International Monetary Fund's Managing Director Kristalina Georgieva appointed Sijbesma to an external advisory group to provide input on policy challenges.[17] Amid the COVID-19 pandemic in the Netherlands, he was asked to support the Dutch government's special envoy on the pandemic response in early 2020, especially focused on testing.[18]
Since mid-2020, Sijbesma focuses on several boards (a.o. chairman of Royal Philips and Unilever), as well as climate (adaptation). He co-chairs with former UN SG Ban Ki-moon the Global Center on Adaptation (GCA). In 2023, United Nations Secretary-General António Guterres appointed Sijbesma as one of 22 members of the Scaling Up Nutrition (SUN) Movement's lead group.[19]